Home    Back

Quercetin    (DrugBank: Quercetin)

5 diseases
IDDisease name (Link within this page)Number of trials
84Sarcoidosis1
85Idiopathic interstitial pneumonia1
192Cockayne syndrome1
285Fanconi anemia2
299Cystic fibrosis1

84. Sarcoidosis    [ 143 clinical trials,   221 drugs,   (DrugBank: 79 drugs),   82 drug target genes,   165 drug target pathways]
Searched query = "Sarcoidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 143 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00402623
(ClinicalTrials.gov)		January 200620/11/2006The Effect of Quercetin in SarcoidosisThe Effect of Quercetin on the Increased Inflammatory and Decreased Antioxidant Status in SarcoidosisSarcoidosisDietary Supplement: quercetin;Other: placeboMaastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedN/AN/AAll18N/ANetherlands

85. Idiopathic interstitial pneumonia    [ 514 clinical trials,   377 drugs,   (DrugBank: 108 drugs),   97 drug target genes,   204 drug target pathways]
Searched query = "Idiopathic interstitial pneumonia", "IIPs", "Idiopathic pulmonary fibrosis", "IPF", "Usual interstitial pneumonia", "UIP", "Non-specific interstitial pneumonia", "NSIP", "Acute interstitial pneumonia", "AIP", "Diffuse alveolar damage", "DAD", "COP", "Organizing pneumonia", "OP", "Desquamative interstitial pneumonia", "DIP", "Respiratory bronchiolitis - associated interstitial lung disease", "RB-ILD", "Lymphocytic interstitial pneumonia", "LIP"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 514 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02874989
(ClinicalTrials.gov)		December 16, 201617/8/2016Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human TrialTargeted Removal of Pro-Inflammatory Cells: An Open Label Human Pilot Study in Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)Drug: Dasatinib + Quercetin;Drug: PlaceboWake Forest University Health SciencesMayo Clinic;The University of Texas Health Science Center at San AntonioCompleted50 YearsN/AAll26Phase 1United States

192. Cockayne syndrome    [ 4 clinical trials,   7 drugs,   (DrugBank: 3 drugs),   1 drug target gene,   50 drug target pathways]
Searched query = "Cockayne syndrome", "CS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 4 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1ChiCTR1900026719
2019-11-012019-10-19Clinical study for combined application of vitamin C and quercetin in the treatment of Cockayne's syndromeClinical study for combined application of vitamin C and quercetin in the treatment of Cockayne's syndrome Cockayne's syndrometest group:Vitamin C and Quercetin;The First Medical Center of PLA General HospitalNULLPending613Bothtest group:20;China

285. Fanconi anemia    [ 56 clinical trials,   111 drugs,   (DrugBank: 31 drugs),   30 drug target genes,   151 drug target pathways]
Searched query = "Fanconi anemia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 56 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03476330
(ClinicalTrials.gov)		May 8, 201819/3/2018Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi AnemiaQuercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi AnemiaFanconi Anemia;Squamous Cell CarcinomaDrug: Quercetin (dietary supplement)Children's Hospital Medical Center, CincinnatiNULLRecruiting2 YearsN/AAll55Phase 2United States
2NCT01720147
(ClinicalTrials.gov)		July 201225/7/2012Quercetin in Children With Fanconi Anemia; a Pilot StudyQuercetin in Children With Fanconi Anemia; a Pilot StudyFanconi AnemiaDrug: Quercetin (dietary supplement)Children's Hospital Medical Center, CincinnatiFood and Drug Administration (FDA)RecruitingN/AN/AAll32Phase 1United States

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1,592 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01348204
(ClinicalTrials.gov)		March 20101/6/2010Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) ModulatorsNasal Potential Studies Utilizing CFTR Modulators (UAB Center for Clinical and Translational Science)Cystic FibrosisOther: quercetinUniversity of Alabama at BirminghamNational Institutes of Health (NIH)Completed8 Years65 YearsBoth32Phase 2United States

Back to top